Literature DB >> 1414493

Perspective. How many women have osteoporosis?

L J Melton1, E A Chrischilles, C Cooper, A W Lane, B L Riggs.   

Abstract

Osteoporosis is widely viewed as a major public health concern, but the exact magnitude of the problem is uncertain and likely to depend on how the condition is defined. Noninvasive bone mineral measurements can be used to define a state of heightened fracture risk (osteopenia), or the ultimate clinical manifestation of fracture can be assessed (established osteoporosis). If bone mineral measurements more than 2 standard deviations below the mean of young normal women represent osteopenia, then 45% of white women aged 50 years and over have the condition at one or more sites in the hip, spine, or forearm on the basis of population-based data from Rochester, Minnesota. A smaller proportion is affected at each specific skeletal site: 32% have bone mineral values this low in the lumbar spine, 29% in either of two regions in the proximal femur, and 26% in the midradius. Although this overall estimate is substantial, some other serious chronic diseases are almost as common. More importantly, low bone mass is associated with adverse health outcomes, especially fractures. The lifetime risk of any fracture of the hip, spine, or distal forearm is almost 40% in white women and 13% in white men from age 50 years onward. If the enormous costs associated with these fractures are to be reduced, increased attention must be given to the design and implementation of control programs directed at this major health problem.

Entities:  

Mesh:

Year:  1992        PMID: 1414493     DOI: 10.1002/jbmr.5650070902

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  300 in total

Review 1.  Statins and bones.

Authors:  M H Moghadasian; J J Frohlich
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

2.  Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology.

Authors:  E M Scott; I Gaywood; B B Scott
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

Review 3.  Diagnosis of postmenopausal osteoporosis: reviews in endocrine and metabolic disorders.

Authors:  A T Shields; C H Chesnut
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 4.  Osteoporosis in men.

Authors:  G M Prelevic
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

Review 5.  Clinical nutrition: 2. The role of nutrition in the prevention and treatment of adult osteoporosis.

Authors:  S A Atkinson; W E Ward
Journal:  CMAJ       Date:  2001-11-27       Impact factor: 8.262

6.  Influence of bone densitometry results on the treatment of osteoporosis.

Authors:  N S Fitt; S L Mitchell; A Cranney; K Gulenchyn; M Huang; P Tugwell
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

7.  Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women.

Authors:  S Bharadwaj; A G T Naidu; G V Betageri; N V Prasadarao; A S Naidu
Journal:  Osteoporos Int       Date:  2009-01-27       Impact factor: 4.507

8.  Sex steroids during bone growth: a comparative study between mouse models for hypogonadal and senile osteoporosis.

Authors:  J Ophoff; K Venken; F Callewaert; S Boonen; R Bouillon; D Vanderschueren
Journal:  Osteoporos Int       Date:  2009-02-24       Impact factor: 4.507

9.  [Minimally invasive therapy of painful osteoporotic vertebral fractures].

Authors:  P Krepler; J G Grohs
Journal:  Radiologe       Date:  2003-09       Impact factor: 0.635

10.  Variations in nanomechanical properties and tissue composition within trabeculae from an ovine model of osteoporosis and treatment.

Authors:  Jayme C Burket; Daniel J Brooks; Jennifer M MacLeay; Shefford P Baker; Adele L Boskey; Marjolein C H van der Meulen
Journal:  Bone       Date:  2012-10-23       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.